Evidence map›Paper›PMID 39269102›Full record

ArticleNanomaterials (Basel, Switzerland)2024

Potential of Enzymatically Synthesized Hemozoin Analog as Th1 Cell Adjuvant.

Kazuaki Hoshi, Anh Thi Tram Tu, Miwako Shobo, Karin Kettisen, Lei Ye, Leif Bülow, Yoji Hakamata, Tetsuya Furuya, Ryutaro Asano, Wakako Tsugawa and 3 more

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Kazuaki HoshiResearch Center for Macromolecules and Biomaterials, National Institute for Materials Science (NIMS), Tsukuba 305-0047, Japan.
Anh Thi Tram TuResearch Center for Macromolecules and Biomaterials, National Institute for Materials Science (NIMS), Tsukuba 305-0047, Japan.
Miwako ShoboResearch Center for Macromolecules and Biomaterials, National Institute for Materials Science (NIMS), Tsukuba 305-0047, Japan.
Karin KettisenDivision of Pure and Applied Biochemistry, Department of Chemistry, Lund University, 22100 Lund, Sweden.
Lei YeDivision of Pure and Applied Biochemistry, Department of Chemistry, Lund University, 22100 Lund, Sweden.ORCID 0000-0002-3646-4072
Leif BülowDivision of Pure and Applied Biochemistry, Department of Chemistry, Lund University, 22100 Lund, Sweden.ORCID 0000-0003-4966-8610
Yoji HakamataSchool of Veterinary Nursing and Technology, Nippon Veterinary and Life Science University, Musashino 180-8602, Japan.ORCID 0000-0002-0138-6692
Tetsuya FuruyaCooperative Department of Veterinary Medicine, Faculty of Agriculture, Tokyo University of Agriculture and Technology, Fuchu 183-8509, Japan.ORCID 0000-0003-3979-7072
Ryutaro AsanoDepartment of Biotechnology and Life science, Graduate School of Engineering, Tokyo University of Agriculture and Technology, Koganei 184-8588, Japan.ORCID 0000-0001-6795-8377
Wakako TsugawaDepartment of Biotechnology and Life science, Graduate School of Engineering, Tokyo University of Agriculture and Technology, Koganei 184-8588, Japan.ORCID 0000-0001-6299-5267
Kazunori IkebukuroDepartment of Biotechnology and Life science, Graduate School of Engineering, Tokyo University of Agriculture and Technology, Koganei 184-8588, Japan.ORCID 0000-0003-2838-0562
Koji SodeJoint Department of Biomedical Engineering, The University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, NC 27599, USA.ORCID 0000-0002-9833-2091
Tomohiko YamazakiResearch Center for Macromolecules and Biomaterials, National Institute for Materials Science (NIMS), Tsukuba 305-0047, Japan.ORCID 0000-0003-2136-8042

Funding

Japan Society for the Promotion of Science 15K06589Japan Society for the Promotion of Science 17KK0122Tsukuba Clinical Research&Development Organization A18-58
6 · The paper itself

Abstract

Hemozoin (Hz) is a heme crystal produced during malaria infection that stimulates immune cells, leading to the production of cytokines and chemokines. The immunostimulatory action of Hz has previously been applied in the development of alternative adjuvants. Crystallization of hemin is a chemical approach for producing Hz. Here, we focused on an enzymatic production method for Hz using the heme detoxification protein (HDP), which catalyzes heme dimer formation from hemin in

Indexed as

adjuvantheme detoxification proteinhemozoin analogTh-1 immunityvaccine

Identifiers

PMID39269102
PMCPMC11397214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.